Regional expansion Verdi Oncology has recently expanded into Texas with a dedicated cancer research center, signaling a growth trajectory beyond Tennessee and potential for cross-state collaborations with hospitals and independent practices seeking access to clinical trials and oncology services.

Clinical research focus The company emphasizes clinical innovation and early clinical trials, presenting opportunities to partner with research sites, contract research organizations, and physician practices aiming to offer patients cutting-edge therapies and value-based research programs.

Provider network growth Acquisitions and partnerships in 2019 indicate a strategy to scale through integrating independent oncology practices, suggesting sales potential for practice management services, revenue-cycle support, and shared infrastructure solutions.

Technology footprint A lean tech stack focused on compliance, form management, and content delivery points to potential for selling integrated practice management, health information security, patient engagement, and digital marketing enhancements to similar oncology networks.

Financial opportunity With revenue in the low to mid single-digit millions and a target market of small to mid-sized oncology practices, there is room to offer scalable solutions that improve efficiency, grant access to clinical trials, and support value-based care models.